Lenalidomide and haemoglobin decreased Patient Reports February 11, 2012

Lenalidomide Side Effects Report #5003496-X
Lenalidomide side effect was reported by a Physician from UNITED STATES on Apr 29, 2006. Female patient, 87 years of age, weighting 88.18 lb, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: back pain , cerebral atrophy, delirium, encephalopathy, haemoglobin decreased, hyponatraemia, transient ischaemic attack. Lenalidomide dosage: 25 MG, QD ON DAYS 1-21 Q28D, ORAL. During the same period patient was treated with DEXAMETHASONE, DARVOCET, DURAGESIC, FERROUS SULPHATE, MIRALAX, PROTONIX, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.

Lenalidomide Side Effects Report #4951603-7
Lenalidomide side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2006. Female patient, 85 years of age, weighting 166.2 lb, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: erythema multiforme, haemoglobin decreased, stevens-johnson syndrome, toxic epidermal necrolysis. Lenalidomide dosage: 25 MG, QD ON DAYS 1-21, Q28D, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Lenalidomide Side Effects Report #4975855-2
Lenalidomide side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2006. Male patient, 64 years of age, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, blood bilirubin increased, chills, haemoglobin decreased, hypokalaemia, jaundice , neutrophil count decreased, platelet count decreased. Lenalidomide dosage: 25 MG, QD X21D, Q28D, ORAL. Patient was hospitalized. Patient recovered.

Lenalidomide Side Effects Report #5801768-X
Lenalidomide side effect was reported by a Health Professional from UNITED STATES on July 03, 2008. Male patient, weighting 124.3 lb, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood phosphorus increased, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, refusal of treatment by patient. Lenalidomide dosage: 25MG QD X 21 DAYS/MO PO. During the same period patient was treated with DEXAMETHASONE, OXYCONTIN, PRILOSEC, BACTRIM DS, ARANESP, MIRALAX. Patient was hospitalized. Patient recovered.


Lenalidomide Side Effects Report #5007457-6
Lenalidomide side effect was reported by a Health Professional from UNITED STATES on May 19, 2006. Male patient, weighting 217.0 lb, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: colonic polyp , dizziness , haematocrit decreased, haemoglobin decreased, large intestinal ulcer, melaena. Lenalidomide dosage: 25MG QD X 21 DAYS PO. During the same period patient was treated with DEXAMETHASONE, SYNTHROID, SOTALOL, NEURONTIN, PLAVIX. Patient was hospitalized. Patient recovered.

Lenalidomide Side Effects Report #6125354-X
Lenalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2009. Male patient, weighting 147.3 lb, was diagnosed with hodgkin's disease  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: cough, disease progression, haemoglobin decreased, pyrexia, vomiting. Lenalidomide dosage: 25 MG/DAY PO. During the same period patient was treated with VALTREX, OXYCODONE. Patient was hospitalized. Patient recovered.